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INTRODUCTION: Mesenchymal stem cells are a 
potential source of cells for the repair of bone and 
articular cartilage defects. We have previously 
demonstrated that the infrapatellar synovial fat pad 
is a rich source of mesenchymal stem cells and 
these cells are able to undergo osteogenic and 
chondrogenic differentiation 1, 2. Although synovial 
fat pad derived mesenchymal stem cells may 
represent a heterogenous population, clonal 
populations derived from the synovial fat pad have 
not previously been studied.  
METHODS: Mesenchymal stem cells were 
isolated from the infrapatellar synovial fat pad of a 
patient undergoing total knee arthroplasty and 
expanded in culture. Six clonal populations were 
also isolated before initial plating using limiting 
dilution and expanded. The cells from the mixed 
parent population and the derived clonal 
populations were characterised for stem cell 
surface epitopes, and then cultured in osteogenic 
medium for 21 days and as cell aggregates in 
chondrogenic medium for 14 days. Gene 
expression analyses; alizarin red staining; alkaline 
phosphatase, glycosoaminoglycan and DNA 
assays; and immunohistochemical staining were 
determined to assess osteogenic and chondrogenic 
responses. 
RESULTS: Cells from the mixed parent 
population and the derived clonal populations 
stained strongly for markers of adult mesenchymal 
stem cells including CD44, CD90 and CD105, and 
they were negative for the haematopoietic marker 
CD34 and for the neural and myogenic marker 
CD56. Aa variable number of cells were also 
positive for the pericyte marker 3G5 both in the 
mixed parent and clonal populations. The clonal 
populations exhibited a variable osteogenic and 
chondrogenic response; two clonal cell populations 
exhibited a significantly greater osteogenic 
response, and one clonal cell population exhibited 
a significantly greater chondrogenic response when 
compared with the mixed parent population. 
Results for immunohistochemical staining for 
collagen I, collagen II, and aggrecan, and Safranin 
O staining for the six clonal populations and the 
mixed population are shown in the figure. 
 
Figure: Immunohistochemical staining for 
collagen I, collagen II, and aggrecan, and 
Safranin O staining for the six clonal populations 
and the mixed population. 
DISCUSSION & CONCLUSIONS: Pericytes are 
a candidate stem cell in many tissue and our results 
show that all six clonal populations derived from 
the heterogenous synovial fat pad population 
express the pericyte marker 3G5. The variable 
osteogenic and chondrogenic responses suggest 
inherent differences between these populations. 
The osteogenic and chondrogenic potential of the 
synovial fat pad could be optimised by the 
identification of clonal populations with a 
propensity to differentiate down particular 
differentiation pathways. 
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